SCHEMBL30291155

SCHEMBL30291155

C[C@H](O)[C@H](C)n1cc(-c2nc(N)ncc2C(F)(F)F)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.40
▸ JAK1 P23458 8/20 0.40
▸ TYK2 P29597 8/20 0.40
▸ JAK3 P52333 8/20 0.40
▸ LRRK2 Q5S007 2/20 0.33
▸ CDK1 P06493 5/20 0.33
▸ CDK4 P11802 5/20 0.33
▸ CCNB1 P14635 5/20 0.33
▸ CCND1 P24385 5/20 0.33
▸ CCNE1 P24864 5/20 0.33
▸ CDK2 P24941 5/20 0.33
▸ CCND3 P30281 5/20 0.33
▸ CDK6 Q00534 5/20 0.33
▸ MAP3K12 Q12852 3/20 0.32
▸ FGFR3 P22607 1/20 0.32
▸ KDM5B Q9UGL1 1/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ CDK7 P50613 1/20 0.32
▸ CDK9 P50750 1/20 0.32
▸ CCNH P51946 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30291203 1.00 JAK2 (0.40) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL30291206 1.00 JAK2 (0.40) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL30291204 1.00 JAK2 (0.40) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL30291151 1.00 JAK2 (0.40) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL30291343 0.73 CCNE1 (0.55) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL30291371 0.71 CCNE1 (0.46) JAK2JAK1TYK2JAK3CDK1
SCHEMBL30291190 0.70 CCNE1 (0.35) LRRK2CDK1CDK4CCNB1CCND1
SCHEMBL30291149 0.70 CCNE1 (0.35) LRRK2CDK1CDK4CCNB1CCND1
SCHEMBL29527516 0.68 JAK2 (0.46) JAK2JAK1TYK2JAK3KDM5B
SCHEMBL1334325 0.67 ADORA1 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355742-A1 SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2024-04-24 — — EP disclosed
CN-117813300-A Substituted pyrimidinyl-pyrazoles as CDK2 inhibitors 缆图药品公司 2024-04-02 — — CN disclosed
WO-2022266190-A1 SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2022-12-22 — — WO disclosed
Send feedback